ArticleGhana medical journal2025
The burden and trends of Hepatitis B virus at a government hospital in Ghana.
Article in Ghana medical journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study determined the burden and trend of Hepatitis B Virus (HBV) infection in individuals who visited Agona Government Hospital in Ghana. Design: A retrospective study. Setting: A single-centre study conducted at Agona Government Hospital. Participants: Clients who visited Agona Government Hospital. Main outcome measure: A hospital-based retrospective study was conducted. Data generated between January 2016 and December 2020 were extracted, cleaned, and validated using Microsoft Excel version 2019. Analysis was done using the Statistical Package for Social Sciences version 26. Results: A total of 2440 records from individuals who were tested for HBV were analysed. The records indicated varying numbers of tests each year, with 28.9% in 2016, 23.1% in 2017, 20.6% in 2018, 13.6% in 2019, and 13.7% in 2020. Most of the clients were aged 25-44 (46.3%). The majority of the clients were married (53.2%) and females (65.3%). The cumulative crude prevalence of HBV infection was 57.44 per 10,000. The prevalence of HBV varied across age categories and genders. A decline in prevalence was observed from 2016 to 2017, with a trough in 2018, followed by a rise through 2019 and peaking in 2020. The crude prevalence exhibited a peak in February and a trough in September, with inconsistent patterns throughout the year. Conclusion: The high burden of HBV underscores its significance as a pressing public health issue. There is therefore an urgent need for public health interventions to curb the spread of the infection. Funding: None declared.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.